Sun Pharmaceutical Industries on Wednesday reported a consolidated net profit of ₹2,654.58 crore in the fourth quarter ended March.
The company had posted a consolidated net profit of ₹1,984.47 crore in the fourth quarter of the previous fiscal.
Consolidated total revenue from operations was at ₹11,982.9 crore against ₹10,930.67 crore in the same quarter a year ago.
India formulation sales were at ₹3,707.8 crore, while US formulation sales were at $476 million (around ₹3,964 crore) in the fourth quarter.
Sun Pharma said the results for the quarter ended December 31, 2023, and the quarter and the year ended March 31, 2024, are not comparable with other periods due to the acquisition of a 60 per cent shareholding in Vivaldis Health and Foods, which was completed during the quarter ended June 30, 2023.
The board has recommended a final dividend of ₹5 per equity share of Re 1 each.
This is in addition to the interim dividend of ₹8.5 per share paid in FY24, taking the total dividend for FY24 to ₹13.5 per share compared with ₹11.5 per share for FY23, it added.
The board of directors also approved the appointment of managing director Dilip Shanghvi as the chairman of the board with immediate effect.
Jubilant profit soars
Jubilant Foodworks has reported a multi-fold increase in its consolidated net profit at ₹208.24 crore for the quarter ended March 31, helped by exceptional item gains.
The company, which operates Domino’s Pizza and Dunkin’ Donuts, had posted a net profit of ₹28.54 crore a year ago. Revenue from operations rose 23.85 per cent to ₹1,572.79 crore from ₹1,269.84 crore in the year-ago period.
JFL’s total income, including other income, rose 23.61 per cent to ₹1,594.12 crore in the March quarter.
Nykaa net up four-fold
FSN E-Commerce Ventures, owner of the Nykaa brand, has posted a nearly four-fold jump in consolidated net profit at ₹9 crore for the March quarter. The company had registered a net profit of ₹2.27 crore a year ago.
The consolidated revenue from operations increased 28 per cent to ₹1,668 crore during the quarter from ₹1,302 crore in the March 2023 quarter.
